3:58
Subcutaneous rituximab versus intravenous rituximab – safety and efficacy results
Andrew Davies
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

The content of VJHemOnc is intended for healthcare professionals